The role of fish oil in arrhythmia prevention - PubMed (original) (raw)
Review
The role of fish oil in arrhythmia prevention
Rishi G Anand et al. J Cardiopulm Rehabil Prev. 2008 Mar-Apr.
Abstract
Numerous epidemiological studies, case-control series, and randomized trials have demonstrated the ability of fish oil to reduce major cardiovascular events, particularly sudden cardiac death and all-cause mortality. We discuss the potential benefits of fish oil therapy to improve overall autonomic tone and potentially reduce the risk of major ventricular and atrial arrhythmias. Specifically, this review focuses on how fish oil therapy has performed in 3 primary prevention trials in patients with implantable cardioverter defibrillators, reviews the effects that fish oil has on the autonomic nervous system, focuses on the use of fish oil as a novel therapy for atrial fibrillation, and revisits other beneficial properties of fish oil (ie, ability to lower serum triglycerides, anti-inflammatory effects, and possible improvements in arterial pressure/diastolic function). We also discuss the safety profile of fish oil, including effects on bleeding time and bleeding complications as well as provide commentary regarding fish oil supplementation in light of increasing contaminants contained in fish. In summary, any patient with documented coronary heart disease and those with risk factors for sudden cardiac death, such as left ventricular dysfunction, left ventricular hypertrophy, prior myocardial infarction, or high-grade ventricular dysrhythmias, should consider fish oil supplementation. The American Heart Association recommends four 3-ounce servings of oily fish weekly. For those who cannot eat fish or do not have access to fish, as well as those who would prefer not to eat fish regularly, capsules of fish oil are readily available in various concentrations. At the present time, we recommend doses of eicosapentanoic acid and docosahexanoic acid in the combined range of 800 to 1000 mg/day for primary and secondary prevention of cardiovascular disease.
Similar articles
- Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D; Fatty Acid Antiarrhythmia Trial Investigators. Leaf A, et al. Circulation. 2005 Nov 1;112(18):2762-8. doi: 10.1161/CIRCULATIONAHA.105.549527. Circulation. 2005. PMID: 16267249 Clinical Trial. - n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease.
Brouwer IA, Geelen A, Katan MB. Brouwer IA, et al. Prog Lipid Res. 2006 Jul;45(4):357-67. doi: 10.1016/j.plipres.2006.02.004. Epub 2006 Apr 18. Prog Lipid Res. 2006. PMID: 16678270 Review. - [Fish fatty acids and cardiovascular diseases--an update].
Brouwer IA, Katan MB. Brouwer IA, et al. Ned Tijdschr Geneeskd. 2008 Sep 13;152(37):2009-14. Ned Tijdschr Geneeskd. 2008. PMID: 18825888 Review. Dutch. - Fish oil and heart health.
de Leiris J, de Lorgeril M, Boucher F. de Leiris J, et al. J Cardiovasc Pharmacol. 2009 Nov;54(5):378-384. doi: 10.1097/FJC.0b013e3181af6c56. J Cardiovasc Pharmacol. 2009. PMID: 19568180 Review. - [Omega-3 fatty acids, fish, fish oil and cardiovascular disease--a review with implications to Israeli nutritional guidelines].
Eilat-Adar S, Lipovetzky N, Goldbourt U, Henkin Y. Eilat-Adar S, et al. Harefuah. 2004 Aug;143(8):585-91, 622, 621. Harefuah. 2004. PMID: 15523812 Review. Hebrew.
Cited by
- Emergency Medicine Update: What's New in Cardiovascular Disease.
Lavie CJ. Lavie CJ. Ochsner J. 2009 Spring;9(1):2-3. Ochsner J. 2009. PMID: 21603400 Free PMC article. No abstract available. - Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
Darwesh AM, Bassiouni W, Sosnowski DK, Seubert JM. Darwesh AM, et al. Pharmacol Ther. 2021 Mar;219:107703. doi: 10.1016/j.pharmthera.2020.107703. Epub 2020 Oct 5. Pharmacol Ther. 2021. PMID: 33031856 Free PMC article. Review. - A fish a day, keeps the cardiologist away! - A review of the effect of omega-3 fatty acids in the cardiovascular system.
Peter S, Chopra S, Jacob JJ. Peter S, et al. Indian J Endocrinol Metab. 2013 May;17(3):422-9. doi: 10.4103/2230-8210.111630. Indian J Endocrinol Metab. 2013. PMID: 23869297 Free PMC article. - Omega-3 fatty acids: cardiovascular benefits, sources and sustainability.
Lee JH, O'Keefe JH, Lavie CJ, Harris WS. Lee JH, et al. Nat Rev Cardiol. 2009 Dec;6(12):753-8. doi: 10.1038/nrcardio.2009.188. Epub 2009 Oct 27. Nat Rev Cardiol. 2009. PMID: 19859067 Review. - Matter of Fat: Are Lipids Antiarrhythmic?
Wan E, Boyden PA. Wan E, et al. Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1313-5. doi: 10.1161/CIRCEP.115.003636. Circ Arrhythm Electrophysiol. 2015. PMID: 26671935 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical